Canada markets open in 4 hours 51 minutes

Helix BioPharma Corp. (HBP.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.4600-0.0100 (-2.13%)
At close: 12:25PM EST
Currency in CAD

Valuation Measures

Market Cap (intraday) 576.21M
Enterprise Value 373.98M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)58.18
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 7-8.77

Trading Information

Stock Price History

Beta (5Y Monthly) -0.14
52-Week Change 374.07%
S&P500 52-Week Change 326.88%
52 Week High 31.1600
52 Week Low 30.2500
50-Day Moving Average 30.5476
200-Day Moving Average 30.7778

Share Statistics

Avg Vol (3 month) 316.2k
Avg Vol (10 day) 314.12k
Shares Outstanding 5141.13M
Implied Shares Outstanding 6N/A
Float 8119.93M
% Held by Insiders 115.02%
% Held by Institutions 118.57%
Shares Short (Nov. 14, 2021) 444.52k
Short Ratio (Nov. 14, 2021) 42.1
Short % of Float (Nov. 14, 2021) 40.04%
Short % of Shares Outstanding (Nov. 14, 2021) 40.03%
Shares Short (prior month Oct. 14, 2021) 430.74k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul. 30, 2020
Most Recent Quarter (mrq)Apr. 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-129.66%
Return on Equity (ttm)-334.48%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-8.74M
Diluted EPS (ttm)-0.0540
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.27M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)34k
Total Debt/Equity (mrq)2.60
Current Ratio (mrq)1.71
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-9.39M
Levered Free Cash Flow (ttm)-4.7M